Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3159-3161

  Musa, Humberto R ^a,b   Ambroggi, Marta ^a,b   Souto, Alejandro ^a,b   Ängeby, K A Kristian ^c,d  

^a HOSPITAL F J MUÑIZ   (Argentina)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; NITRATE REDUCTASE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; COST CONTROL; DEVELOPING COUNTRY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; VALIDATION PROCESS;

ANTITUBERCULAR AGENTS; ARGENTINA; COLORIMETRY; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE; NITRATE REDUCTASES; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

BACILLI; MYCOBACTERIUM TUBERCULOSIS;

EID: 22144478686     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3159-3161.2005     Document Type: Article

References (22)

1. Angeby, K. A. K., L. Klintz, and S. E. Hoffner. 2002. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40:553-555.
2. Angeby, K. A. K., J. Werngren, J. C. Toro, G. Hedstrom, B. Petrini, and S. E. Hoffner. 2003. Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin. Microbiol. Infect. 9:1148-1152.
3. Bemer, P., F. Palicova, S. Rüsch-Gerdes, H. B. Drugeon, and G. E. Pfyffer. 2002. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:150-154.
4. Canetti, G., N. Rist, and J. Grosset. 1963. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Reune Tuberc. Pneumol. T27 23:217-272.
5. Centers for Disease Control and Prevention. 2002. TB elimination cooperative agreement. Centers for Disease Control and Prevention, Atlanta, Ga.
6. 5a.Coban, A. Y., A. Birinci, B. Ekinci, and B. Durupinar. 2004. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int. J. Antimicrob. Agents 24:304-306.
7. 5b.Fleiss, J. L. 1981. Statistical methods for rates and proportions, 2nd ed. Wiley Interscience, New York, N.Y.
8. Goloubeva, V., M. Lecocq, P. Lassowsky, F. Matthys, F. Portaels, and I. Bastian. 2001. Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J. Clin. Microbiol. 39: 1501-1505.
9. Golyshevskaia, V. I., A. A. Korneev, L. N. Chernousova, L. G. Selina, T. A. Kazarova, T. D. Grishina, S. G. Safonova, V. A. Puzanov, G. M. Nikolaeva, and N. I. Fadeeva. 1996. New microbiological techniques in diagnosis of tuberculosis. Probl. Tuberk. 6:22-25.
10. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga.
11. Lemus, D., A. Martin, E. Montoro, F. Portaels, and J. C. Palomino. 2004. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. [Online.] http://jac .oupjournals.org/.
12. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, P. Nunn, et al. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
13. Palmero, D., V. Ritacco, M. Ambroggi, M. Natiello, L. Barrera, L. Capone, A. Dambrosi, M. di Lonardo, N. Isola, S. Poggi, M. Vescovo, and E. Abbate. 2003. Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg. Infect. Dis. 9:965-969.
14. Pan American Health Organization. 1973. Manual de bacterilogía de la TBC: tecnicas y procedimientos básicos. OPS, Washington, D.C.
15. Syre, H., S. Phyu, P. Sandven, B. Bjorvatn, and H. M. S. Grewal. 2003. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid Culture. J. Clin. Microbiol. 41:5173-5177.
16. Tison F., and B. Carbonnelle. 1972. Recherche, isolament et etude du bacille tuberculeux et des autres mycobacteries eu pratique courante, p. 239-240. Crouan et Roques, Paris, France.
17. Tortoli, E., M. Benedetti, A. Fontanelli, and T. Simonetti. 2002. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J. Clin. Microbiol. 40:607-610.
18. Turett, G. S., E. E. Telzak, L. V. Torian, S. Blum, D. Alland, I. Weisfuse, and B. A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21:1238-1244.
19. Vareldzis, B. P., J. Grosset, I. De Kantor, J. Crofton, A. Laszlo, M. Felten, M. C. Raviglione, and A. Kochi. 1994. Drug-resistant tuberculosis: laboratory issues: World Health Organization recommendations. Tuberc. Lung Dis. 75:1-7.
20. Williams-Bouyer, N., R. Yorke, H. I. Lee, and G. L. Woods. 2000. Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria. J. Clin. Microbiol. 38:4167-4170.
21. World Health Organization. 2000. The W.H.O./IUATLD global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world, report no. 2: prevalence and trends. World Health Organization, Geneva, Switzerland.
22. Sethi, S., S. Sharma, S. K. Sharma, S. K. Meharwal, S. K. Jindal, and M. Sharma. 2004. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J. Med. Res. 120:468-471.